Barely Significant
← all excerpts

Revefenacin: First Global Approval.

Drugs · 2019 · PMC6445810 · PMID 30560478

Europe PMCDOI
1
hedged sentence
0.4810
closest p · 9.6× alpha
0.4810
boldest claim

The sentences

did not reach statistical significancep = 0.481not close (p > 0.1)
On day 29, revefenacin and tiotropium effectively improved trough FEV 1 and FVC from baseline, with improvements numerically favouring revefenacin over tiotropium; however, these differences did not reach statistical significance (FEV 1 : p = 0.481; FVC: p = 0.104).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.